Immunohistochemical detection of prostate-specific antigen expression in primary urothelial carcinoma of the urinary bladder

Jung Chin Chen, Chung Liang Ho, Hung Wen Tsai, Tzong Shin Tzai, Hsiao Sheng Liu, Nan Haw Chow, Wen Horng Yang, Hong Lin Cheng

研究成果: Article

9 引文 (Scopus)

摘要

Background: Prostate-specific antigen (PSA) is a 33-kDa serine protease that is secreted by prostatic epithelium and non-prostate tissues. Ectopic expression of PSA has also been reported in a variety of non-prostatic epithelial tumors. Patients and Methods: Expression of PSA and its clinical implication were examined in a total of 422 cases of primary urothelial carcinoma of the bladder. Results: Cytoplasmic reactivity to PSA was observed in 6 cases (1.4%), with the staining being to a low degree in 3 and a high degree in the remaining 3 cases. Expression of PSA was positively related to multiplicity, large tumors (≥3 cm) and muscle invasion (≥pT2) (p=0.0008, 0.004 and 0.03, respectively). Patients with tumors of low PSA expression had a better survival than those with tumors of high PSA expression (p=0.03). Conclusion: Focal expression of PSA can occasionally be detected in some large, invasive urothelial cancer cells. This phenotypic change should be considered in the differential diagnosis of poorly differentiated carcinoma of the lower urinary tract.

原文English
頁(從 - 到)4149-4154
頁數6
期刊Anticancer research
28
發行號6 B
出版狀態Published - 2008 十一月 1

指紋

Prostate-Specific Antigen
Urinary Bladder
Carcinoma
Neoplasms
Serine Proteases
Urinary Tract
Differential Diagnosis
Epithelium
Staining and Labeling
Muscles
Survival

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

引用此文

@article{cced78fa1eff428fb5f83c60f766835a,
title = "Immunohistochemical detection of prostate-specific antigen expression in primary urothelial carcinoma of the urinary bladder",
abstract = "Background: Prostate-specific antigen (PSA) is a 33-kDa serine protease that is secreted by prostatic epithelium and non-prostate tissues. Ectopic expression of PSA has also been reported in a variety of non-prostatic epithelial tumors. Patients and Methods: Expression of PSA and its clinical implication were examined in a total of 422 cases of primary urothelial carcinoma of the bladder. Results: Cytoplasmic reactivity to PSA was observed in 6 cases (1.4{\%}), with the staining being to a low degree in 3 and a high degree in the remaining 3 cases. Expression of PSA was positively related to multiplicity, large tumors (≥3 cm) and muscle invasion (≥pT2) (p=0.0008, 0.004 and 0.03, respectively). Patients with tumors of low PSA expression had a better survival than those with tumors of high PSA expression (p=0.03). Conclusion: Focal expression of PSA can occasionally be detected in some large, invasive urothelial cancer cells. This phenotypic change should be considered in the differential diagnosis of poorly differentiated carcinoma of the lower urinary tract.",
author = "Chen, {Jung Chin} and Ho, {Chung Liang} and Tsai, {Hung Wen} and Tzai, {Tzong Shin} and Liu, {Hsiao Sheng} and Chow, {Nan Haw} and Yang, {Wen Horng} and Cheng, {Hong Lin}",
year = "2008",
month = "11",
day = "1",
language = "English",
volume = "28",
pages = "4149--4154",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "6 B",

}

TY - JOUR

T1 - Immunohistochemical detection of prostate-specific antigen expression in primary urothelial carcinoma of the urinary bladder

AU - Chen, Jung Chin

AU - Ho, Chung Liang

AU - Tsai, Hung Wen

AU - Tzai, Tzong Shin

AU - Liu, Hsiao Sheng

AU - Chow, Nan Haw

AU - Yang, Wen Horng

AU - Cheng, Hong Lin

PY - 2008/11/1

Y1 - 2008/11/1

N2 - Background: Prostate-specific antigen (PSA) is a 33-kDa serine protease that is secreted by prostatic epithelium and non-prostate tissues. Ectopic expression of PSA has also been reported in a variety of non-prostatic epithelial tumors. Patients and Methods: Expression of PSA and its clinical implication were examined in a total of 422 cases of primary urothelial carcinoma of the bladder. Results: Cytoplasmic reactivity to PSA was observed in 6 cases (1.4%), with the staining being to a low degree in 3 and a high degree in the remaining 3 cases. Expression of PSA was positively related to multiplicity, large tumors (≥3 cm) and muscle invasion (≥pT2) (p=0.0008, 0.004 and 0.03, respectively). Patients with tumors of low PSA expression had a better survival than those with tumors of high PSA expression (p=0.03). Conclusion: Focal expression of PSA can occasionally be detected in some large, invasive urothelial cancer cells. This phenotypic change should be considered in the differential diagnosis of poorly differentiated carcinoma of the lower urinary tract.

AB - Background: Prostate-specific antigen (PSA) is a 33-kDa serine protease that is secreted by prostatic epithelium and non-prostate tissues. Ectopic expression of PSA has also been reported in a variety of non-prostatic epithelial tumors. Patients and Methods: Expression of PSA and its clinical implication were examined in a total of 422 cases of primary urothelial carcinoma of the bladder. Results: Cytoplasmic reactivity to PSA was observed in 6 cases (1.4%), with the staining being to a low degree in 3 and a high degree in the remaining 3 cases. Expression of PSA was positively related to multiplicity, large tumors (≥3 cm) and muscle invasion (≥pT2) (p=0.0008, 0.004 and 0.03, respectively). Patients with tumors of low PSA expression had a better survival than those with tumors of high PSA expression (p=0.03). Conclusion: Focal expression of PSA can occasionally be detected in some large, invasive urothelial cancer cells. This phenotypic change should be considered in the differential diagnosis of poorly differentiated carcinoma of the lower urinary tract.

UR - http://www.scopus.com/inward/record.url?scp=58149172199&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58149172199&partnerID=8YFLogxK

M3 - Article

C2 - 19192675

AN - SCOPUS:58149172199

VL - 28

SP - 4149

EP - 4154

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 6 B

ER -